SCHEMBL6623025

SCHEMBL6623025

Cc1cc(CCNC(=O)c2ccccc2C=O)on1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 4/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ HDAC1 Q13547 3/20 0.46
▸ MAPK1 P28482 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ POLB P06746 3/20 0.42
▸ HDAC4 P56524 1/20 0.41
▸ HDAC7 Q8WUI4 1/20 0.41
▸ HDAC11 Q96DB2 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC9 Q9UKV0 1/20 0.41
▸ HDAC5 Q9UQL6 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ GLA P06280 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ AKR1C3 P42330 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12955391 0.74 NPC1 (0.47) SMN1; SMN2RAB9ANPC1KMT2AALDH1A1
SCHEMBL24696326 0.74 TSHR (0.57) POLBALDH1A1L3MBTL1
SCHEMBL14186001 0.74 HPGD (0.47) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL2123261 0.74 ALDH1A1 (0.44) SMN1; SMN2RAB9ANPC1MAPK1MEN1
SCHEMBL6609811 0.72 ALDH1A1 (0.51) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL2665746 0.72 TSHR (0.73) SMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18074482 0.71 HTT (0.53) SMN1; SMN2NPC1POLBALDH1A1HSD17B10
SCHEMBL11953188 0.71 TSHR (0.45) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL14185996 0.71 MAOB (0.47) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL6616501 0.71 TSHR (0.45) SMN1; SMN2RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456182-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF INSULINE-LIKE GROWTH FACTOR-1 RECEPTOR (IGF-I) AstraZeneca AB (SE) 2004-09-15 — — EP disclosed
WO-2003048133-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF INSULINE-LIKE GROWTH FACTOR-1 RECEPTOR (IGF-I) ASTRAZENECA AB (SE) 2003-06-12 — — WO disclosed
Send feedback